Latest News about XNAS:ABVC
Recent news which mentions XNAS:ABVC
BioLite, Inc., an ABVC BioPharma Subsidiary, Receives $230,000 Milestone Payment from AiBtl, Advancing Botanical Drug Licensing Collaboration
August 27, 2025
Tickers
ABVC
Tickers
ABVC
Tickers
ABVC
OncoX Deepens ABVC Alliance
August 01, 2025
Tickers
ABVC
ABVC BioPharma Strengthens Oncology Partnership With $100,000 Milestone Payment From OncoX BioPharma
July 24, 2025
Tickers
ABVC
ABVC BioPharma Records $100,000 Licensing Milestone From ForSeeCon, Strengthening Eye Health Program
July 18, 2025
Tickers
ABVC
ABVC BioPharma Receives $150K Milestone From AiBtl, Bringing Total Licensing Revenue to $846K Across Strategic Partnerships
July 10, 2025
Tickers
ABVC
ABVC BioPharma CEO Dr. Uttam Patil Recognized Among Elite Indian-Origin CEOs Making Global Impact in Science and Technology
June 26, 2025
Tickers
ABVC
ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment
June 24, 2025
Tickers
ABVC
ABVC BioPharma Expands Oncology Portfolio as Affiliate OncoX Acquires Patented Lycopenoid Platform Valued at $4.06 Million
June 06, 2025
Tickers
ABVC
Tickers
ABVC
Tickers
ABVC
ABVC BioPharma Secures Japanese Patent for Its Natural MDD Treatment Candidate ABV-1504
May 09, 2025
Tickers
ABVC
Tickers
ABVC
UPDATE: ABVC BioPharma Announces 2024 Financial Results
April 16, 2025
Tickers
ABVC
ABVC BioPharma Announces 2024 Financial Results
April 15, 2025
Tickers
ABVC
ABVC BioPharma Announces 2024 Financial Results
April 15, 2025
Tickers
ABVC
ABVC's Subsidiary AiBtl Signs Share-for-Land Agreement in Asia With Deal Valued at USD $7.67 Million
April 03, 2025
Tickers
ABVC
ABVC BioPharma Maintains Lucrative Global Licensing Agreements and Promising CDMO Acquisition, Strengthening Growth Potential
March 19, 2025
Tickers
ABVC
ABVC BioPharma Plans to Expand Investment in U.S. for Production Facilities and Products for Unmet Medical Needs
March 05, 2025
Tickers
ABVC
ABVC and BioLite Japan Implement Strategy to Advance Japan's Biotech Innovation Into Global Markets
February 26, 2025
Tickers
ABVC
ABVC BioPharma Announces Potential $7M Cash Licensing Income from Existing Agreements in 2025
February 20, 2025
Tickers
ABVC
Positive Market Response in Asia Fuels Potential Revenue Growth for ABVC and BioKey, Marching Into Global Dietary Supplements Market of USD 75.35 Billion
February 12, 2025
Tickers
ABVC
ABVC BioPharma and AiBtl BioPharma's Worldwide Business Development Team Participate in the 43rd Annual J.P. Morgan Healthcare Conference
January 16, 2025
Tickers
ABVC
Tickers
ABVC
AiBtl BioPharma Strengthens Partnership With ABVC BioPharma, Paying $150,000 in Licensing Fees
January 14, 2025
Tickers
ABVC
ABVC BioPharma, Inc. Granted Additional 180-Day Grace Period to Regain Compliance With Nasdaq Bid Price Requirement
January 13, 2025
Tickers
ABVC
Tickers
ABVC
Tickers
ABVC